British American Tobacco Coinvests in German Cannabis with Snoop Dogg

One of the world’s largest tobacco companies, British American Tobacco (BAT), has invested in German startup Sanity Group GmbH. Joining the tobacco giant is Casa Verde Capital, a fund owned by rapper Snoop Dogg. BAT is investing in cannabis to diversify its revenues beyond tobacco.

For more news like this, download our free cannabis news app.

British American Tobacco Invests in the German Cannabis Industry

According to founder and CEO Finn Age Hänsel, Berlin-based Sanity Group has received $37.6 million in a Series B funding round led by British American Tobacco. The startup has earmarked nearly half of the investment to strengthen Sanity’s medical business. The company will use the rest to prepare for the potential legalization of cannabis in Germany.

Germany is Europe’s largest economy, with more than 83 million people. British American Tobacco now hopes that the government will fulfill its promises to legalize cannabis.

British American Tobacco Investment Exemplifies a New Trend

The British American Tobacco investment epitomizes a new trend: cannabis is the future, while tobacco – particularly cigarettes – is increasingly a relic of the past. In 2019, a report showed that more Americans would soon be smoking cannabis than tobacco. It only took three years for this trend to be confirmed.

A Gallup survey last month found that just 11% of Americans identified themselves as cigarette smokers, the lowest in history. In contrast, 16% said they considered themselves regular cannabis smokers.

British American Tobacco Expects Germany to Legalize Cannabis

Germany has not yet legalized cannabis for recreational use, but this is likely to happen sooner rather than later. At least, this is the bet that British American Tobacco is making.

So far, several European countries have stated their intention to legalize, but for the moment, they have ended with nothing further than a simple declaration of intent.

However, Germany’s coalition government is “actively working on it and really wants to come up with a good bill by the end of this year,” said Hänsel, CEO of Sanity Group. “It’s really a priority topic for the government.”

Hänsel said that as the stock value of cannabis companies is falling due to fears of a recession, current conditions are making it difficult for cannabis startups to raise cash.

Germany Gives Hope to Other Investors

Nevertheless, the mood in Germany has been fueled by recent reports of the upcoming legalization of cannabis. With Health Minister Karl Lauterbach’s support and Justice Minister Marco Buschmann’s optimism that the law could be passed by next spring, corporations like British American Tobacco are already looking for a place to join the growing industry.

Public support is also growing in Europe, as medical cannabis is already legal in almost all of Europe, and the boom in CBD products has changed the public’s perception of cannabis after decades of stigma.

About Sanity Group GmbH

Founded in 2018, Sanity Group GmbH focuses on the production and distribution of hemp-based pharmaceuticals, medical products and consumer goods.

Founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, Sanity Group is backed financially and strategically by investors such as Casa Verde Capital (Snoop Dogg), Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital and various angel investors and celebrities such as Will. i.am (Black Eyed Peas), Scooter Braun, Hollywood actress Alyssa Milano and German soccer player Mario Götze. Now, British American Tobacco joins this list.

Last year, British American Tobacco acquired a stake in Canadian hemp producer Organigram and invested in Trait Biosciences, which provides the technology that makes CBD water-soluble.

—

(Featured image by Philafrenzy (CC BY-SA 4.0) via Wikimedia Commons)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published by Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.